31
Participants
Start Date
March 22, 2016
Primary Completion Date
July 18, 2017
Study Completion Date
December 14, 2017
ADVAGRAF®
"Administration method The total daily dose of tacrolimus will be converted to 1:1 (mg:mg) and the total daily dose of ADVAGRAF® will be administered only once daily in the morning, starting from Day 1 (at least one hour before breakfast or 2 to 3 hours after breakfast).~* Dose adjustment after conversion On Day 1, the total dose will be converted to 1:1. It is recommended to check the blood concentration of tacrolimus at each visit and adjust the dose to achieve the blood concentration maintaining at 5\~8ng/ml for 0 to 3 months and then at 5ng/ml or below for 3 to 6 months of study treatment.~* Duration of treatment The investigational product will be administered for 24 weeks."
Collaborators (1)
Astellas Pharma Korea, Inc.
INDUSTRY
Linical Korea
INDUSTRY
Kim, Seoung-Hoon
OTHER_GOV